A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

NCT06951711 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder Type I With Mania or Mania With Mixed Features

Interventions

DRUG: KarXT
OTHER: Placebo

Sponsor

Bristol-Myers Squibb